Xencor reported $742.34M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amgen AMGN:US $ 2419M 1503M
Arrowhead Research ARWR:US $ 453.93M 1.66M
AstraZeneca AZN:LN 2951310.75M 184237.79M
Biogen BIIB:US $ 11872.5M 630.2M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Cytokinetics CYTK:US $ 111.41M 4.85M
Epizyme EPZM:US $ -20.28M 31.4M
GlaxoSmithKline GSK:LN 1637400M 19300M
Karyopharm Therapeutics KPTI:US $ -116338000 33.26M
Macrogenics MGNX:US $ 142.48M 35.73M
Novartis NOVN:VX SF 62925M 1385M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Xencor XNCR:US $ 742.34M 20.68M